Clinical and Translational Discovery is a peer-reviewed english-language open-access journal published by Wiley in Australia, operating under an open-access model since 2021. The journal covers Therapeutics. Pharmacology.
Authors are required to pay an article processing charge to publish in Clinical and Translational Discovery; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
Keywords
gene therapy, transcriptional networks, translational medicine, diagnosis
At a glance
ISSN
- electronic
- 2768-0622
Frequently asked questions
Is Clinical and Translational Discovery peer-reviewed?
Yes — Clinical and Translational Discovery operates a Anonymous peer review review process.
Does Clinical and Translational Discovery charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Clinical and Translational Discovery publish?
Clinical and Translational Discovery publishes research in Therapeutics. Pharmacology.
What languages does Clinical and Translational Discovery accept?
Clinical and Translational Discovery accepts manuscripts in English.
What is the ISSN of Clinical and Translational Discovery?
ISSN:
2768-0622 (electronic).How do I submit a manuscript to Clinical and Translational Discovery?
Submit through the journal's official portal: visit submission page →